Umeda, Y., Morikawa, M., Anzai, M., Kadowaki, M., Waseda, Y., Tsujikawa, T., . . . Mori, T. Predictive value of 3′-deoxy-3′-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer. BMJ Publishing Group.
Chicago Style (17th ed.) CitationUmeda, Yukihiro, et al. Predictive Value of 3′-deoxy-3′-18F-fluorothymidine PET in the Early Response to Anti-programmed Death-1 Therapy in Patients with Advanced Non-small Cell Lung Cancer. BMJ Publishing Group.
MLA (9th ed.) CitationUmeda, Yukihiro, et al. Predictive Value of 3′-deoxy-3′-18F-fluorothymidine PET in the Early Response to Anti-programmed Death-1 Therapy in Patients with Advanced Non-small Cell Lung Cancer. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.